CONSOLIDATED BALANCE SHEETS - USD ($) shares in Thousands, $ in Millions	Sep. 27, 2025	Sep. 28, 2024
Current assets:
Cash and cash equivalents	$ 35,934	$ 29,943
Marketable securities	18,763	35,228
Accounts receivable, net	39,777	33,410
Vendor non-trade receivables	33,180	32,833
Inventories	5,718	7,286
Other current assets	14,585	14,287
Total current assets	147,957	152,987
Non-current assets:
Marketable securities	77,723	91,479
Property, plant and equipment, net	49,834	45,680
Other non-current assets	83,727	74,834
Total non-current assets	211,284	211,993
Total assets	359,241	364,980
Current liabilities:
Accounts payable	69,860	68,960
Other current liabilities	66,387	78,304
Deferred revenue	9,055	8,249
Commercial paper	7,979	9,967
Term debt	12,350	10,912
Total current liabilities	165,631	176,392
Non-current liabilities:
Term debt	78,328	85,750
Other non-current liabilities	41,549	45,888
Total non-current liabilities	119,877	131,638
Total liabilities	285,508	308,030
Commitments and contingencies
Common stock, shares outstanding (in shares)	14,773,260	15,116,786
Common stock, shares issued (in shares)	14,773,260	15,116,786
Shareholders’ equity:
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 14,773,260 and 15,116,786 shares issued and outstanding, respectively	$ 93,568	$ 83,276
Accumulated deficit	(14,264)	(19,154)
Accumulated other comprehensive loss	(5,571)	(7,172)
Total shareholders’ equity	73,733	56,950
Total liabilities and shareholders’ equity	$ 359,241	$ 364,980